Berkshire Capital Holdings’s Repligen RGEN Stock Holding History

Berkshire Capital Holdings’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-51,520	Closed	-$14.9M	–	92
2021 Q3	$14.9M	Buy	+51,520	New	+$13.2M	2%	22

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Berkshire Capital Holdings's RGEN Position: Q4 2021 in Review

Berkshire Capital Holdings sold out of Repligen (RGEN) in Q4 2021, closing a stake of 51,520 shares — an estimated $14.9M sold.

Berkshire Capital Holdings first reported a position in RGEN in Q3 2021 and held it in 1 quarter. The position peaked at $14.9M in Q3 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

Berkshire Capital Holdings reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
Berkshire Capital Holdings sold 51,520 Repligen shares in Q4 2021, an estimated $14.9M.
Berkshire Capital Holdings first reported a position in Repligen in Q3 2021 and held it in 1 quarter.
Berkshire Capital Holdings's Repligen position peaked at $14.9M in Q3 2021.
507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Berkshire Capital Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.